## Confirmatory Investigations for Trachoma **Key Point:** PCR for Chlamydia trachomatis DNA is the gold standard and most specific investigation for confirming active trachoma, with sensitivity >95% and specificity >99%. ### Why PCR is Superior PCR detects bacterial DNA directly and is: - **Most sensitive** — detects organisms even in early or subclinical infection - **Most specific** — differentiates C. trachomatis from other chlamydial species - **Most reliable** — not dependent on staining quality or observer skill - **Gold standard** — recommended by WHO and international guidelines for diagnosis and surveillance ### Comparison of Diagnostic Methods | Investigation | Sensitivity | Specificity | Advantages | Limitations | |---|---|---|---|---| | **PCR** | >95% | >99% | Gold standard, detects DNA, highly specific | Cost, requires lab infrastructure | | **Giemsa staining** | 50–60% | High | Rapid, inexpensive, shows inclusion bodies | Operator-dependent, low sensitivity | | **Immunofluorescence** | 80–90% | >95% | Good sensitivity, specific antibodies | Requires fluorescence microscopy, expertise | | **Viral culture** | Not applicable | Not applicable | Not used for Chlamydia | Chlamydia is obligate intracellular bacterium, not a virus | **High-Yield:** In endemic areas with limited resources, Giemsa staining may be used for screening, but PCR is the confirmatory test of choice. **Clinical Pearl:** PCR can detect C. trachomatis in asymptomatic carriers and is essential for epidemiological surveys and monitoring treatment response in trachoma elimination programmes. [cite:Park 26e Ch 8] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.